NCT01568099 Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's Disease Status COMPLETED Phase PHASE1
NCT01568073 Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon Status COMPLETED Phase PHASE3
NCT01568047 Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients Status COMPLETED Phase PHASE2
NCT01568034 A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067 Status COMPLETED Phase PHASE2
NCT01563913 Reducing Dyskinesia in Parkinson's Disease With Omega-3 Fatty Acids Status COMPLETED Phase PHASE1
NCT01563341 Tandem DBS for Parkinson's Disease: A Pilot Study Utilizing STN/GPi + Hypothalamic Stimulation Status COMPLETED Phase NA
NCT01560754 Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease Status UNKNOWN Phase PHASE2
NCT01556165 Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China Status COMPLETED Phase PHASE3
NCT01550484 A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders Status COMPLETED Phase PHASE2/PHASE3
NCT01545414 Internet-CBT (Cognitive Behavioral Therapy) for Depression and Anxiety in Parkinsons Disease Status COMPLETED Phase PHASE3
NCT01544465 Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's Disease Status TERMINATED Phase NA
NCT01539837 A Pilot Clinical Trial With the Iron Chelator Deferiprone in Parkinson's Disease Status COMPLETED Phase PHASE2
NCT01536769 Intestinal and Nasal Microbiota of Patients With Idiopathic Parkinson's Disease Status COMPLETED Phase N/A